Xiaofang Wang

475 total citations
16 papers, 392 citations indexed

About

Xiaofang Wang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Xiaofang Wang has authored 16 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Xiaofang Wang's work include interferon and immune responses (6 papers), Ubiquitin and proteasome pathways (5 papers) and Immune Cell Function and Interaction (4 papers). Xiaofang Wang is often cited by papers focused on interferon and immune responses (6 papers), Ubiquitin and proteasome pathways (5 papers) and Immune Cell Function and Interaction (4 papers). Xiaofang Wang collaborates with scholars based in China and United States. Xiaofang Wang's co-authors include Yukang Yuan, Hui Zheng, Liting Zhang, Qiao Cheng, Yibo Zuo, Liping Qian, Tingting Guo, Yan Ge, Qian Feng and Yi‐Hua Zhou and has published in prestigious journals such as Immunity, Biochemical and Biophysical Research Communications and PLoS Pathogens.

In The Last Decade

Xiaofang Wang

16 papers receiving 392 citations

Peers

Xiaofang Wang
Galaxia M. Rodriguez Canada
Dilan Dissanayake Canada
Elise Holvey-Bates United States
Jesse S. Handler United States
SuJin Hwang United States
Heath L. Bradley United States
Bee Shin Tan Australia
Joanna Pancewicz Poland
Mi Li China
Galaxia M. Rodriguez Canada
Xiaofang Wang
Citations per year, relative to Xiaofang Wang Xiaofang Wang (= 1×) peers Galaxia M. Rodriguez

Countries citing papers authored by Xiaofang Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Wang more than expected).

Fields of papers citing papers by Xiaofang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Wang. The network helps show where Xiaofang Wang may publish in the future.

Co-authorship network of co-authors of Xiaofang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Wang. A scholar is included among the top collaborators of Xiaofang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Wang. Xiaofang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhang, Ge, Xiaolin Cui, Zhenpeng Qin, et al.. (2023). Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability. iScience. 26(9). 107587–107587. 9 indexed citations
2.
Pu, Zhangya, Jinghua Liu, Zelong Liu, et al.. (2022). STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment. Cancer Cell International. 22(1). 314–314. 10 indexed citations
3.
Liang, Yuejin, Xiaofang Wang, Hui Wang, et al.. (2021). IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8+ T cells. Immunology. 165(1). 61–73. 22 indexed citations
4.
Yuan, Yukang, Ying Miao, Jin Liu, et al.. (2019). Small‐molecule inhibitors of ubiquitin‐specific protease 7 enhance type‐I interferon antiviral efficacy by destabilizing SOCS1. Immunology. 159(3). 309–321. 13 indexed citations
5.
Zhang, Liting, Jin Liu, Liping Qian, et al.. (2018). Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome. PLoS Pathogens. 14(5). e1007067–e1007067. 86 indexed citations
6.
Wang, Xiaofang, et al.. (2018). Comparison of Dynamic Changes in Periodontal Health Between Patients Receiving Lingual and Labial Orthodontics. Journal of Biomaterials and Tissue Engineering. 8(9). 1370–1374. 1 indexed citations
7.
Wang, Xiaofang, Liting Zhang, Yunli Zhang, et al.. (2017). JOSD1 Negatively Regulates Type-I Interferon Antiviral Activity by Deubiquitinating and Stabilizing SOCS1. Viral Immunology. 30(5). 342–349. 17 indexed citations
8.
Cheng, Qiao, Yukang Yuan, Lemin Li, et al.. (2017). Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis. Experimental Cell Research. 356(1). 1–7. 5 indexed citations
9.
Zhao, Peng, Tingting Guo, Liping Qian, et al.. (2017). Ubiquitin C-terminal hydrolase-L3 promotes interferon antiviral activity by stabilizing type I-interferon receptor. Antiviral Research. 144. 120–129. 17 indexed citations
10.
Qian, Guanghui, Ying Ren, Yibo Zuo, et al.. (2016). Smurf1 represses TNF-α production through ubiquitination and destabilization of USP5. Biochemical and Biophysical Research Communications. 474(3). 491–496. 14 indexed citations
11.
Ren, Ying, Peng Zhao, Jin Liu, et al.. (2016). Deubiquitinase USP2a Sustains Interferons Antiviral Activity by Restricting Ubiquitination of Activated STAT1 in the Nucleus. PLoS Pathogens. 12(7). e1005764–e1005764. 39 indexed citations
12.
Liu, Cong-Lin, Deliang Shen, Junnan Tang, et al.. (2014). Characterization of interleukin-33 and matrix metalloproteinase-28 in serum and their association with disease severity in patients with coronary heart disease. Coronary Artery Disease. 25(6). 498–504. 14 indexed citations
13.
Chang, Xing, Fang Liu, Xiaofang Wang, et al.. (2011). The Kinases MEKK2 and MEKK3 Regulate Transforming Growth Factor-β-Mediated Helper T Cell Differentiation. Immunity. 34(2). 201–212. 43 indexed citations
14.
Wang, Xiaofang, Kun Wei, Zhihe Zhang, et al.. (2009). Major histocompatibility complex Class IIDRBexon‐2 diversity of the Eurasian lynx (Lynx lynx) in China. Journal of Natural History. 43(3-4). 245–257. 16 indexed citations
15.
Zhou, Yi‐Hua, et al.. (2007). 4IgB7‐H3 is the major isoform expressed on immunocytes as well as malignant cells. Tissue Antigens. 70(2). 96–104. 41 indexed citations
16.
Wang, Xiaofang, Yan Ge, Qiang Dai, et al.. (2006). Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells. Tissue Antigens. 69(2). 145–153. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Galaxia M. Rodriguez Breakdown of academic impact, for papers by Dilan Dissanayake Breakdown of academic impact, for papers by Elise Holvey-Bates Breakdown of academic impact, for papers by Jesse S. Handler Breakdown of academic impact, for papers by SuJin Hwang Breakdown of academic impact, for papers by Heath L. Bradley Breakdown of academic impact, for papers by Bee Shin Tan Breakdown of academic impact, for papers by Joanna Pancewicz Breakdown of academic impact, for papers by Mi Li
Rankless by CCL
2026